Holen Sie sich die Stockscreener-App
1.34
1.52%
0.02
Schlusskurs vom Vortag:
$1.32
Offen:
$1.3
24-Stunden-Volumen:
4,151
Relative Volume:
0.04
Marktkapitalisierung:
$22.50M
Einnahmen:
$48.43M
Nettoeinkommen (Verlust:
$-11.04M
KGV:
-2.00
EPS:
-0.67
Netto-Cashflow:
$-7.00M
1W Leistung:
-4.96%
1M Leistung:
+50.54%
6M Leistung:
-18.29%
1J Leistung:
-33.33%
1-Tages-Spanne:
$1.30
$1.3889
1-Wochen-Bereich:
$1.30
$1.53
52-Wochen-Spanne:
$0.782
$2.14
Iridex Corp Stock (IRIX) Company Profile
Firmenname
Iridex Corp
Sektor
Branche
Telefon
(650) 940-4700
Adresse
1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA
Vergleichen Sie IRIX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRIX
Iridex Corp
|
1.34 | 23.34M | 48.43M | -11.04M | -7.00M | -0.67 |
|
ABT
Abbott Laboratories
|
126.91 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.06 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
379.89 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.88 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.34 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Iridex Corp Stock (IRIX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2017-11-03 | Fortgesetzt | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2016-01-26 | Eingeleitet | Singular Research | Buy |
| 2007-01-03 | Eingeleitet | First Albany | Buy |
Iridex Corp Aktie (IRIX) Neueste Nachrichten
Is IRIDEX Corporation a growth stock or a value stockExpert Picks Outlook To Watch Now - jammulinksnews.com
Comparing IRIDEX Corporation in custom built stock radarsScalable Strategy with Chart Confirmation - Newser
What is the risk reward ratio of investing in IRIDEX Corporation stockLow Risk Report For Consistent Profits - jammulinksnews.com
Is IRIDEX Corporation showing signs of accumulationCapital Growth Summary Over Five Years - Newser
Analyzing IRIDEX Corporation with multi timeframe chartsFree Earnings Play Trade Plan With Alerts - Newser
When is the best time to buy IRIDEX Corporation stockFree Weekly Stock Watch With Growth Focus - Newser
Will IRIDEX Corporation stock go up soonShort-Term Upside Breakout Forecast System - Newser
How IRIDEX Corporation stock performs during market volatilityFree Market Entry and Exit Point Tips - Newser
Iridex Corporation to Announce Q2 2025 Financial Results and Business Update on August 12, 2025 - Quiver Quantitative
Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025 - The Manila Times
Medical Laser Leader Iridex Announces Q2 2025 Earnings Call Details - Stock Titan
RSI Suggests Rebound May Be Near in IRIDEX CorporationReal-Time Analysis With Entry Targets In Progress - beatles.ru
Tools to assess IRIDEX Corporation’s risk profileFuture Growth Stock Forecasting Strategy - Newser
Sentiment Tools Show Shift in Trader Mood on IRIDEX CorporationFast Entry High Potential Stock Alerts Triggered - metal.it
What is the dividend policy of IRIDEX Corporation stockCapitalize on fast-growing investment opportunities - jammulinksnews.com
What are analysts’ price targets for IRIDEX Corporation in the next 12 monthsUnlock expert trading strategies for growth - jammulinksnews.com
What institutional investors are buying IRIDEX Corporation stockAccess high-yield investment alerts now - jammulinksnews.com
Intrinsic Value of IRIDEX Corporation Stock: Is It Undervalued or OvervaluedFree Real-Time Stock Data - Newser
What analysts say about IRIDEX Corporation stockAccelerated earnings growth - PrintWeekIndia
What drives IRIDEX Corporation stock priceRobust financial gains - PrintWeekIndia
IRIDEX Corporation Stock Analysis and ForecastConsistent high-yield stocks - Autocar Professional
Retinal Detachment Market Set for Steady Expansion by 2032, - openPR.com
Is IRIDEX Corporation a good long term investmentExceptional growth trajectory - Autocar Professional
Why IRIDEX Corporation stock attracts strong analyst attentionTrade With Low Risk Exposure - Newser
What makes IRIDEX Corporation stock price move sharplyTop Performing Low Risk Stocks - Newser
What caused IRIX's earnings surprises in 2024? - AInvest
Iridex corp director William Moore acquires $19,372 in stock By Investing.com - Investing.com South Africa
Iridex corp director William Moore acquires $19,372 in stock - Investing.com
Iridex corp CEO Patrick Mercer buys $240 in common stock By Investing.com - Investing.com Canada
Iridex corp CEO Patrick Mercer buys $240 in common stock - Investing.com Australia
IRIDEX expands stock plan and amends charter - Investing.com
IRIDEX expands stock plan and amends charter By Investing.com - Investing.com UK
Iridex director William Moore buys $29,121 in stock By Investing.com - Investing.com South Africa
Iridex director William Moore buys $29,121 in stock - Investing.com
Iridex corp CFO Romeo Dizon acquires shares worth $197 By Investing.com - Investing.com Nigeria
Iridex corp CFO Romeo Dizon acquires shares worth $197 - Investing.com
IRIDEX amends agreement with Novel Inspiration International - Investing.com
IRIDEX amends agreement with Novel Inspiration International By Investing.com - Investing.com India
IRIDEX Faces Nasdaq Delisting Over Equity Shortfall - Investing.com
IRIDEX (NASDAQ:IRIX) Now Covered by StockNews.com - Defense World
IRIDEX Corporation (NASDAQ:IRIX) Q1 2025 Earnings Call Transcript - Insider Monkey
IRIDEX Corp (IRIX) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic Investments ... - Yahoo
IRIDEX Corp (IRIX) Q1 2025 Earnings Call Highlights: Revenue Gro - GuruFocus
Finanzdaten der Iridex Corp-Aktie (IRIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Iridex Corp-Aktie (IRIX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Mercer Patrick | President and CEO |
Jun 13 '25 |
Buy |
0.96 |
250 |
240 |
386,730 |
| MOORE WILLIAM M | Director |
Jun 12 '25 |
Buy |
0.97 |
20,000 |
19,494 |
168,650 |
| MOORE WILLIAM M | Director |
Jun 11 '25 |
Buy |
0.96 |
10,000 |
9,627 |
148,650 |
| Dizon Romeo R | Chief Financial Officer |
Jun 11 '25 |
Buy |
0.96 |
245 |
236 |
15,245 |
| Dizon Romeo R | Chief Financial Officer |
Jun 09 '25 |
Buy |
0.99 |
500 |
495 |
14,665 |
| Dizon Romeo R | Chief Financial Officer |
Jun 10 '25 |
Buy |
0.98 |
335 |
327 |
15,000 |
| Dizon Romeo R | Chief Financial Officer |
Jun 06 '25 |
Buy |
0.97 |
1,500 |
1,455 |
14,165 |
| Dizon Romeo R | Chief Financial Officer |
Jun 02 '25 |
Buy |
1.00 |
100 |
100 |
12,565 |
| Dizon Romeo R | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.99 |
100 |
99 |
12,665 |
| Dizon Romeo R | Chief Financial Officer |
May 29 '25 |
Buy |
0.98 |
200 |
197 |
12,465 |
1.05%
1.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):